Comparing blood thinner approaches for device surgery in atrial fibrillation
Part of Heart & circulation clinical trials.
This trial compares two ways of managing blood thinners around heart device surgery to find the safest and most effective approach. If you are eligible, you would be randomly assigned to one of the two strategies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You need to be scheduled for a heart device procedure (like getting a pacemaker or defibrillator, or replacing the battery).
- You must be taking a blood thinner pill for at least the past 5 days.
- You need to have atrial fibrillation (irregular heartbeat) or flutter, and either a high stroke risk score or a planned procedure to restore normal rhythm.
- You cannot have an active infection, bleeding, severe kidney disease, very low platelet count, or be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether patients who receive a special device to close a hole in the heart (to prevent stroke from irregular heartbeat) can safely take fewer blood-thinning medications afterward. The study compares taking a standard blood thinner for 3 months versus taking aspirin only, to see which approach works best with fewer bleeding risks.
This trial compares two ways to manage blood-thinning medications after a successful atrial fibrillation ablation, specifically for people who also have a heart stent. It aims to find the safest and most effective strategy to prevent strokes and bleeding.
This study tests the safety of a new blood thinner for people with atrial fibrillation (AFib) who need long-term stroke prevention. If you qualify, the study will compare this medication to standard anticoagulation therapy.
This trial compares which two medicines work best after a device closes off a part of the heart called the left atrial appendage. It may help reduce stroke risk while balancing bleeding risk after your procedure.
This trial tests whether people with atrial fibrillation who have had a successful ablation procedure can safely stop taking blood thinners (NOACs) if they wear a monitor to check for any silent heart rhythm problems. It may help you avoid the risks of long-term blood thinner use if your ablation has been effective.
This study tests which blood-thinner approach works best after a procedure to close a small heart pouch (left atrial appendage) with a Watchman device. It aims to prevent strokes while reducing bleeding risks.
Hear when a new Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.